Understand the source comparison
Thymalin vs Thymopentin (TP-5) — Peptide Comparison
Thymalin vs Thymopentin (TP-5) — Peptide Comparison Thymalin vs Thymopentin (TP-5) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Thymalin 5–10 mg Thymopentin (TP-5) 1–2
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
Thymalin vs Thymopentin (TP-5) — Peptide Comparison Thymalin vs Thymopentin (TP-5) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Thymalin 5–10 mg Thymopentin (TP-5) 1–2 mg Frequency Once daily Administration Intramuscular injection Subcutaneous injection Cycle Length 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Limited human trials Moderate human trials (Phase 1-2) Efficacy Immune Restoration Longevity Support Disease Prevention Immune Enhancement Cardiovascular Support Post-Recovery Support Technical Data Molecular Formula Complex mixture; active dipeptide EW: C16H19N3O5 Molecular Weight Polypeptide complex; components 250-1000 Da; active dipeptide EW ~321 Da Half-Life Not precisely characterized for complex; immune effects persist weeks post-administration Bioavailability High via intramuscular or subcutaneous injection CAS Number 63958-90-7 C30H49N9O9 679.8 30 seconds to few minutes in plasma Sustained release via subcutaneous route 69558-55-0 Protocols standard 5-10 mg reconstituted in saline 5-10 day course, often repeated every 6 months Reflects the Russian clinical course used in immune-restoration and gerontology protocols, typically 10 mg IM daily for 5-10 days [1]. advanced 10 mg Up to 20 day course, repeated every 6 months Subcutaneous administration is used in community practice at the same 10 mg daily dosing; longer 20-day courses are described for cyclical immune support [1]. 50 mg Three times weekly 6 weeks to 48 weeks depending on indication Dose used in controlled clinical trials, e.g. 50 mg SC three times weekly in HIV and atopic dermatitis studies [5]. 50 mg by slow IV Repeated injections (e.g. three times weekly) Several weeks Slow intravenous infusion was used in rheumatoid arthritis trials and may enhance in-vivo potency versus bolus dosing [5]. Applications Aging Adults Seeking Immune Support Thymalin is especially valuable for people over 55 whose thymus gland has naturally shrunk with age. By stimulating thymic function, it helps restore the immune training center that your body relies on to fight infections and stay healthy. Longevity and Anti-Aging Protocols Clinical studies tracking patients for 6-8 years showed Thymalin reduced mortality by 2.0-2.1-fold. Combined with Epitalon, the mortality reduction reached an impressive 4.1-fold, making this combination one of the most studied longevity peptide protocols. Seasonal Illness Prevention Research shows Thymalin cuts respiratory infection rates by 2.0-2.4-fold. A short 10-day course before cold and flu season can significantly boost your immune defenses for months afterward. Immune System Enhancement Thymopentin directly increases T-cell function and promotes dendritic cell maturation, making it ideal for people seeking to boost immune response naturally Cardiac Health Support Clinical trials show thymopentin improves ejection fraction and exercise capacity in elderly heart failure patients while enhancing immune markers Post-Surgery Recovery Helps restore immune function after major surgery and protects important immune responses during recovery period Safety Profile Common No side effects in most patients Mild injection site reaction Uncommon Transient low-grade fever Mild flu-like symptoms Temporary headache Serious Severe allergic reaction Local injection site reaction Mild fatigue Transient fever Muscle aches Mild headache Allergic reaction Research Status FDA Status Research compound Safety Overview Thymalin has an excellent safety profile based on over 40 years of clinical use in Russia. Most patients experience zero side effects, and the peptide complex has been described as 'practically non-toxic' in research literature. It has been used safely in thousands of patients, including elderly populations over extended periods. Contraindications xActive thymic tumors or malignancies xKnown hypersensitivity to animal-derived peptide products xPregnancy and breastfeeding (insufficient safety data) xSevere uncontrolled autoimmune disease without medical supervision Thymopentin is well-tolerated with minimal side effects reported in clinical trials. Most adverse events are mild and local. No serious safety concerns have emerged from decades of clinical use in China and Europe. xPregnancy and breastfeeding xActive malignancy (without medical supervision) xSevere immunosuppression xHypersensitivity to peptide medications Decision Guide Choose Thymalin if... Immune system restoration in aging adults Longevity and healthy aging support Reducing infection frequency and severity Multi-system health optimization Choose Thymopentin (TP-5) if... Immune system strengthening Recovering from illness or surgery Managing autoimmune conditions Supporting cardiac health in elderly patients